NGAL

Recombinant NGAL (Neutrophil Gelatinase Associated Lipocalin) is a highly purified renal biomarker produced in E. coli and purified using chromatographic techniques. NGAL is recognized as one of the earliest biomarkers for Acute Kidney Injury (AKI) and is widely utilized in the diagnosis and monitoring of renal disorders. The recombinant mutant form exhibits reduced dimerization through a Cysteine-to-Serine substitution at position 107, providing enhanced stability and consistency for diagnostic assay development. The product is aseptically filtered and formulated to maintain excellent purity, stability, and performance in immunoassays, calibrators, controls, and research applications.